Skip to content
Lower risk Drug recall · FDA · Published September 2, 2025

Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall: Foreign Microorganism Risk

Major Pharmaceuticals recalls 10-tablet sulfamethoxazole-trimethoprim packs with a foreign microorganism in packaging. No tablets were contaminated. Consumers should check product details and contact the manufacturer for guidance.

🇺🇸 FDA recall #D-0625-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling a specific type of antibiotic tablets due to a microorganism found in the packaging material. This does not affect the tablets themselves, but the packaging issue could pose a risk if the packaging is compromised. Read more at govinfonow.com/recall/31818-major-pharmaceuticals-sulfamethoxazole-trimethoprim-recall-foreign-microorganism-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31818-major-pharmaceuticals-sulfamethoxazole-trimethoprim-recall-foreign-microorganism-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0625-2025

Cite this page

“Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall: Foreign Microorganism Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31818-major-pharmaceuticals-sulfamethoxazole-trimethoprim-recall-foreign-microorganism-risk. Based on FDA recall #D-0625-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0625-2025%22&limit=1).

The FDA announced on September 2, 2025, that Major Pharmaceuticals is recalling Sulfamethoxazole and Trimethoprim tablets due to a foreign substance hazard. The recall involves specific lots distributed nationwide in the United States.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1)
  • NDC: 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters)
  • Bag codes: N02309A and N02309B
  • Inner blister lot: N02309
  • Expiration date: 03/31/2027

The hazard

The FDA said the hazard is the presence of a foreign substance, specifically a micro-organism detected on a specific lot of auxiliary polyester coil used in product packaging by manufacturer Amneal Pharmaceuticals LLC. No micro-organism was detected on any tablets.

Context

GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has 14 other recalls on record since May 31, 2023. Recent similar recalls include the Major Chlorpromazine 100mg Tablets Recall (September 12, 2025) and the Major Pharmaceuticals Carvedilol Tablets Recall (August 20, 2025). Other recent recalls of similar products include the Bionpharma Divalproex Tablets Recall (June 26, 2026), the Graviti Furosemide Tablets Recall (January 10, 2026), and the Amerisource Health Primidone Tablets Recall (May 1, 2026).

How to tell if you have this one

Check for the product name 'Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets' in a blister pack with NDC 55154-7895-0. Look for lot numbers N02309A or N02309B with expiration dates of 03/31/2027.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    USA Nationwide.
Recall numberProduct, codes & lotsNDC
D-0624-2025Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61; Lot # N02309, Exp 03/31/20270904-2725-61
D-0625-2025Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per bag, Rx only, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters).; Bag: N02309A and N02309B, Exp Date: 03/31/2027; Inner blister: Lot # N02309, Exp Date: 03/31/202755154-7895-0, 0904-2725-61
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product by checking the NDC code 55154-7895-0 and lot numbers N02309A or N02309B on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Sep 2, 202512. FDA classified it Class II: Sep 10, 202523. Published in FDA’s Enforcement Report: Sep 17, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0625-2025 (September 2, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0625-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA